Chumakov News Today

The official investigation reveals that Russian intelligence successfully planted moles “very close to the leadership of the State Security Service of Ukraine” – What lessons and fallout?

Background Coronavirus disease 2019 (COVID-19) vaccination has substantially altered the course of the pandemic, saving tens of millions of lives globally. The problem is that despite such spectacular results, vaccination alone will not be able to control the COVID-19 pandemic because of the rapid evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) even in vaccinated human populations. Therefore, the development of a post-infection, broad-based, orally administered anti...

According to Aidar Ishmukhametov, the center filed an application with the WHO for CoviVac’s assessment and its subsequent inclusion in the EUL in April 2021

Many believe Vladimir Zhirinovsky, leader of ultra-nationalist Liberal Democratic Party of Russia, has contracted Covid-19 - the very disease he was intending to avoid.

Russia’s Chumakov Federal Scientific Center for the Research and Development of Immune and Biological Products of the Russian Academy of Sciences hopes to receive a license for the use of its CoviVac coronavirus vaccine in children in 2022

The scientist added that such a combination is possible thanks to the fact that the production technology of vaccines against COVID-19 and against flu is "very similar"

In fact, CoviVac coronavirus vaccine was effective against all the known coronavirus mutations

The trials to involve 1,050 volunteers

Earlier, the Russian health ministry issued a license for the third phase of CoviVac clinical tests in children

The Institute of Biomedical Systems and Biotechnologies has joined the Global Virus Network (GVN) and received GVN Center of Excellence status. The institute will develop its activities within the framework of the Federal Strategic Academic Leadershi